Drugs / 5%potassium hydroxide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05895071 Comparator | Nov 2022 → Apr 2023 | common wart | Combined Military Hospital Abbottabad | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5%potassium hydroxide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05895071 ↗ |
| Route | Topical | “topical 5% potassium hydroxide solution” NCT05895071 ↗ |